Tapewire

Nasdaq · USD

MGX

Metagenomi Therapeutics, Inc.

Export transactions ↓
Tapewire entity
7270
SEC CIK
0001785279
Parsed reports
73

Last 12 months

Inside the activity.

2 purchase rows · 13 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202504
Jan 202600
Feb 202600
Mar 202603
Apr 202600
May 202600
Jun 202603
Jul 202600
Aug 202600
Sep 202623
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 09, 2026 Filed Sep 11, 2026 23:51 UTC PurchaseCommon Stock 117 $1.18 $138.06
Disclosure

SEC source: 0001193125-26-389550 · ownership.xml · nonDerivative · entry 2

Reid Laurence · CIK 0001492749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,000

Read SEC document
September 09, 2026 Filed Sep 11, 2026 23:51 UTC PurchaseCommon Stock 19,883 $1.17 $23,263.11
Disclosure

SEC source: 0001193125-26-389550 · ownership.xml · nonDerivative · entry 1

Reid Laurence · CIK 0001492749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,883

F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $1.165 to $1.175. Full information regarding the number of shares purchased at each separate price can be furnished to the SEC staff upon request.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 19:47 UTC
Wein MatthewSee Remarks
SaleCommon Stock 358 $1.16 $414.71
Disclosure

SEC source: 0001193125-26-387816 · ownership.xml · nonDerivative · entry 1

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,133

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 19:40 UTC
Irish JianDirector · See Remarks
SaleCommon Stock 2,140 $1.16 $2,478.98
Disclosure

SEC source: 0001193125-26-387798 · ownership.xml · nonDerivative · entry 1

Irish Jian · CIK 0001995697 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 375,393

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.

Read SEC document
September 08, 2026 Filed Sep 10, 2026 19:34 UTC
Wapnick PamelaChief Financial Officer
SaleCommon Stock 1,911 $1.16 $2,213.70
Disclosure

SEC source: 0001193125-26-387786 · ownership.xml · nonDerivative · entry 1

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 206,580

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 18:31 UTC GrantStock Option (Right to Buy) · Derivative 17,400 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001193125-26-267272 · ownership.xml · derivative · entry 1

Reid Laurence · CIK 0001492749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,400

Underlying: Common Stock · 17,400 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 18:23 UTC GrantStock Option (Right to Buy) · Derivative 21,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001193125-26-267255 · ownership.xml · derivative · entry 1

Dere Willard H · CIK 0001311569 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 17:49 UTC GrantStock Option (Right to Buy) · Derivative 21,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001193125-26-267189 · ownership.xml · derivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 09, 2026 Filed Jun 11, 2026 17:37 UTC GrantStock Option (Right to Buy) · Derivative 21,000 $0.00 Strike: $1.23 $0.00
Disclosure

SEC source: 0001193125-26-267170 · ownership.xml · derivative · entry 1

Eckhardt Juergen · CIK 0001857806 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires 2036-06-08

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2027 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 05, 2026 Filed Jun 10, 2026 15:19 UTC
Wein MatthewSee Remarks
SaleCommon Stock 558 $1.30 $724.84
Disclosure

SEC source: 0001193125-26-265326 · ownership.xml · nonDerivative · entry 1

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 126,491

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.

F2 · balance_after: Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 29, 2026.

Read SEC document
June 05, 2026 Filed Jun 10, 2026 15:23 UTC
Wapnick PamelaChief Financial Officer
SaleCommon Stock 2,884 $1.30 $3,746.32
Disclosure

SEC source: 0001193125-26-265335 · ownership.xml · nonDerivative · entry 1

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 208,491

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.

Read SEC document
June 05, 2026 Filed Jun 10, 2026 15:21 UTC
Irish JianDirector · See Remarks
SaleCommon Stock 3,737 $1.30 $4,854.36
Disclosure

SEC source: 0001193125-26-265332 · ownership.xml · nonDerivative · entry 1

Irish Jian · CIK 0001995697 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 377,533

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.

F2 · balance_after: Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 29, 2026.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 18:00 UTC
Wein MatthewSee Remarks
GrantStock Option (Right to Buy) · Derivative 68,000 $0.00 Strike: $1.34 $0.00
Disclosure

SEC source: 0001193125-26-141914 · ownership.xml · derivative · entry 2

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,000

Underlying: Common Stock · 68,000 shares

Expires 2036-03-31

F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 18:00 UTC
Wein MatthewSee Remarks
GrantCommon Stock 11,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-141914 · ownership.xml · nonDerivative · entry 1

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,549

F1 · shares: These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 18:11 UTC
Irish JianDirector · See Remarks
GrantStock Option (Right to Buy) · Derivative 276,000 $0.00 Strike: $1.34 $0.00
Disclosure

SEC source: 0001193125-26-141946 · ownership.xml · derivative · entry 4

Irish Jian · CIK 0001995697 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 276,000

Underlying: Common Stock · 276,000 shares

Expires 2036-03-31

F4 · derivative.exercise_date: 25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 18:11 UTC
Irish JianDirector · See Remarks
GrantCommon Stock 46,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-141946 · ownership.xml · nonDerivative · entry 1

Irish Jian · CIK 0001995697 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 379,770

F1 · shares: These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 17:40 UTC
Wapnick PamelaChief Financial Officer
GrantStock Option (Right to Buy) · Derivative 144,000 $0.00 Strike: $1.34 $0.00
Disclosure

SEC source: 0001193125-26-141867 · ownership.xml · derivative · entry 2

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 144,000

Underlying: Common Stock · 144,000 shares

Expires 2036-03-31

F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest and become exercisable on April 1, 2027, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2026 Filed Apr 3, 2026 17:40 UTC
Wapnick PamelaChief Financial Officer
GrantCommon Stock 24,000 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-141867 · ownership.xml · nonDerivative · entry 1

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 211,375

F1 · shares: These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2027, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 21:16 UTC
Wein MatthewSee Remarks
SaleCommon Stock 482 $1.60 $771.20
Disclosure

SEC source: 0001193125-26-098821 · ownership.xml · nonDerivative · entry 1

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,549

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on each of April 1, 2024 and April 1, 2025, and does not represent a volitional trade by the Reporting Person.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 21:16 UTC
Wapnick PamelaChief Financial Officer
SaleCommon Stock 1,581 $1.60 $2,529.60
Disclosure

SEC source: 0001193125-26-098824 · ownership.xml · nonDerivative · entry 1

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 187,375

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Read SEC document
March 05, 2026 Filed Mar 9, 2026 21:15 UTC
Irish JianDirector · Chief Executive Officer
SaleCommon Stock 1,607 $1.60 $2,571.20
Disclosure

SEC source: 0001193125-26-098820 · ownership.xml · nonDerivative · entry 2

Irish Jian · CIK 0001995697 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 333,770

F2 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Read SEC document
December 05, 2025 Filed Dec 8, 2025 18:51 UTC
Wein MatthewSee Remarks
SaleCommon Stock 199 $1.77 $352.61
Disclosure

SEC source: 0001193125-25-310958 · ownership.xml · nonDerivative · entry 1

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,031

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Read SEC document
December 05, 2025 Filed Dec 8, 2025 18:56 UTC SaleCommon Stock 3,830 $1.77 $6,786.38
Disclosure

SEC source: 0001193125-25-310971 · ownership.xml · nonDerivative · entry 1

Thomas Brian C. · CIK 0001996097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,510,960

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Read SEC document
December 05, 2025 Filed Dec 8, 2025 18:49 UTC
Wapnick PamelaChief Financial Officer
SaleCommon Stock 1,576 $1.77 $2,792.51
Disclosure

SEC source: 0001193125-25-310953 · ownership.xml · nonDerivative · entry 1

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 188,956

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Read SEC document
December 05, 2025 Filed Dec 8, 2025 18:38 UTC
Irish JianDirector · Chief Executive Officer
SaleCommon Stock 1,602 $1.77 $2,838.58
Disclosure

SEC source: 0001193125-25-310937 · ownership.xml · nonDerivative · entry 1

Irish Jian · CIK 0001995697 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 563,839

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Read SEC document
December 05, 2025 Filed Mar 9, 2026 21:15 UTC
Irish JianDirector · Chief Executive Officer
GiftCommon Stock 228,462 $0.00 $0.00
Disclosure

SEC source: 0001193125-26-098820 · ownership.xml · nonDerivative · entry 1

Irish Jian · CIK 0001995697 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 335,377

F1 · kind: On December 5, 2025, the Reporting Person transferred 114,231 and 114,231 shares of Issuer common stock to the Bruce Irish 2023 Irrevocable Trust FBO Jian Irish and Jian Irish 2023 Irrevocable Trust, respectively, for no consideration.

Read SEC document
December 01, 2025 Filed Dec 1, 2025 23:37 UTC
Wein MatthewSee Remarks
GrantCommon Stock 96,000 $1.60 $153,600.00
Disclosure

SEC source: 0001193125-25-304177 · ownership.xml · nonDerivative · entry 2

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,230

F3 · kind: These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:32 UTC
Wapnick PamelaChief Financial Officer
GrantCommon Stock 120,000 $1.60 $192,000.00
Disclosure

SEC source: 0001193125-25-304218 · ownership.xml · nonDerivative · entry 2

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 190,532

F2 · kind: These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:28 UTC
Irish JianDirector · Chief Executive Officer
GrantStock Option (Right to Buy) · Derivative 225,000 $0.00 Strike: $1.60 $0.00
Disclosure

SEC source: 0001193125-25-304212 · ownership.xml · derivative · entry 4

Irish Jian · CIK 0001995697 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 225,000

Underlying: Common Stock · 225,000 shares

Expires 2035-11-30

F5 · derivative.exercise_date: 25% of the shares subject to this option shall vest and become exercisable on November 6, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:28 UTC
Irish JianDirector · Chief Executive Officer
GrantCommon Stock 211,000 $1.60 $337,600.00
Disclosure

SEC source: 0001193125-25-304212 · ownership.xml · nonDerivative · entry 3

Irish Jian · CIK 0001995697 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 565,441

F4 · kind: These shares represent RSUs. 50% of the RSUs shall vest on December 5, 2026, with the remainder vesting on December 5, 2027, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
December 01, 2025 Filed Dec 2, 2025 00:28 UTC
Irish JianDirector · Chief Executive Officer
GrantCommon Stock 37,500 $1.60 $60,000.00
Disclosure

SEC source: 0001193125-25-304212 · ownership.xml · nonDerivative · entry 2

Irish Jian · CIK 0001995697 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 354,441

F3 · kind: These shares represent RSUs. 25% of the RSUs shall vest on December 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
September 05, 2025 Filed Dec 1, 2025 23:37 UTC
Wein MatthewSee Remarks
SaleCommon Stock 199 $1.81 $360.19
Disclosure

SEC source: 0001193125-25-304177 · ownership.xml · nonDerivative · entry 1

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,230

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units ("RSUs") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

F2 · balance_after: Includes 1,359 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 30, 2025 and 1,377 shares acquired under the Company's ESPP on November 28, 2025.

Read SEC document
September 05, 2025 Filed Dec 2, 2025 00:34 UTC SaleCommon Stock 2,701 $1.81 $4,888.81
Disclosure

SEC source: 0001193125-25-304221 · ownership.xml · nonDerivative · entry 1

Thomas Brian C. · CIK 0001996097 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,514,790

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Read SEC document
September 05, 2025 Filed Dec 2, 2025 00:32 UTC
Wapnick PamelaChief Financial Officer
SaleCommon Stock 1,576 $1.81 $2,852.56
Disclosure

SEC source: 0001193125-25-304218 · ownership.xml · nonDerivative · entry 1

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,532

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units ("RSUs") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

Read SEC document
September 05, 2025 Filed Dec 2, 2025 00:28 UTC
Irish JianDirector · Chief Executive Officer
SaleCommon Stock 1,602 $1.81 $2,899.62
Disclosure

SEC source: 0001193125-25-304212 · ownership.xml · nonDerivative · entry 1

Irish Jian · CIK 0001995697 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 316,941

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the Reporting Person's tax withholding obligations upon the vesting of certain restricted stock units ("RSUs") granted to the Reporting Person on April 1, 2024, and does not represent a volitional trade by the Reporting Person.

F2 · balance_after: Includes 1,500 shares acquired under the Company's employee stock purchase plan ("ESPP") on May 30, 2025 and 1,500 shares acquired under the Company's ESPP on November 28, 2025.

Read SEC document
September 02, 2025 Filed Sep 2, 2025 20:44 UTC GrantStock Option (Right to Buy) · Derivative 42,000 $0.00 Strike: $1.82 $0.00
Disclosure

SEC source: 0000950170-25-112535 · ownership.xml · derivative · entry 1

Reid Laurence · CIK 0001492749 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 42,000

Underlying: Common Stock · 42,000 shares

Expires 2035-09-01

F1 · derivative.exercise_date: 33% of the shares subject to this option shall vest and become exercisable on September 2, 2026, with the remainder vesting in 24 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:36 UTC GrantStock Option (Right to Buy) · Derivative 21,000 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0000950170-25-085488 · ownership.xml · derivative · entry 1

Dere Willard H · CIK 0001311569 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires 2035-06-09

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:33 UTC GrantStock Option (Right to Buy) · Derivative 8,572 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0000950170-25-085483 · ownership.xml · derivative · entry 1

BJERKHOLT ERIC · CIK 0001197350 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8,572

Underlying: Common Stock · 8,572 shares

Expires 2035-06-09

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 10, 2025 Filed Jun 12, 2025 20:43 UTC GrantStock Option (Right to Buy) · Derivative 21,000 $0.00 Strike: $1.57 $0.00
Disclosure

SEC source: 0000950170-25-085499 · ownership.xml · derivative · entry 1

Eckhardt Juergen · CIK 0001857806 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,000

Underlying: Common Stock · 21,000 shares

Expires 2035-06-09

F1 · derivative.exercise_date: The shares subject to this option shall vest and become exercisable upon the earlier of (i) the one-year anniversary of the Grant Date or (ii) the date of the Company's 2026 annual meeting of stockholders, subject to the Reporting Person's continued service with the Issuer on such vesting date.

Read SEC document
June 06, 2025 Filed Jun 9, 2025 23:04 UTC
Wein MatthewSee Remarks
SaleCommon Stock 199 $1.75 $348.25
Disclosure

SEC source: 0000950170-25-083963 · ownership.xml · nonDerivative · entry 1

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,693

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.

Read SEC document
June 06, 2025 Filed Jun 9, 2025 18:57 UTC
Noonberg Sarah B.Chief Medical Officer
SaleCommon Stock 5,239 $1.75 $9,168.25
Disclosure

SEC source: 0000950170-25-083952 · ownership.xml · nonDerivative · entry 1

Noonberg Sarah B. · CIK 0001706301 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,135

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.

Read SEC document
June 06, 2025 Filed Jun 9, 2025 22:50 UTC
Thomas Brian C.Director · Chief Executive Officer
SaleCommon Stock 10,785 $1.75 $18,873.75
Disclosure

SEC source: 0000950170-25-083947 · ownership.xml · nonDerivative · entry 1

Thomas Brian C. · CIK 0001996097 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,517,491

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.

Read SEC document
June 06, 2025 Filed Jun 9, 2025 22:54 UTC
Wapnick PamelaChief Financial Officer
SaleCommon Stock 1,576 $1.75 $2,758.00
Disclosure

SEC source: 0000950170-25-083949 · ownership.xml · nonDerivative · entry 1

Wapnick Pamela · CIK 0001995657 · Chief Financial Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,108

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.

Read SEC document
June 06, 2025 Filed Jun 9, 2025 22:20 UTC
Irish JianDirector · See Remarks
SaleCommon Stock 6,390 $1.75 $11,182.50
Disclosure

SEC source: 0000950170-25-083930 · ownership.xml · nonDerivative · entry 1

Irish Jian · CIK 0001995697 · Director · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 315,543

F1 · kind: These shares of common stock were automatically sold for the purpose of satisfying the reporting person's tax withholding obligations upon the vesting of certain restricted stock units granted to the reporting person on April 1, 2024, and does not represent a volitional trade by the reporting person.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 15:57 UTC
Wein MatthewSee Remarks
GrantStock Option (Right to Buy) · Derivative 22,725 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0000950170-25-050100 · ownership.xml · derivative · entry 4

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 22,725

Underlying: Common Stock · 22,725 shares

Expires 2035-03-31

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 15:57 UTC
Wein MatthewSee Remarks
GrantStock Option (Right to Buy) · Derivative 21,875 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0000950170-25-050100 · ownership.xml · derivative · entry 3

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,875

Underlying: Common Stock · 21,875 shares

Expires 2035-03-31

F3 · derivative.exercise_date: 25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 15:57 UTC
Wein MatthewSee Remarks
GrantCommon Stock 3,775 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-050100 · ownership.xml · nonDerivative · entry 2

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,892

F2 · shares: These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on March 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 15:57 UTC
Wein MatthewSee Remarks
GrantCommon Stock 3,650 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-050100 · ownership.xml · nonDerivative · entry 1

Wein Matthew · CIK 0002009713 · See Remarks

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,117

F1 · shares: These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 11:56 UTC
Noonberg Sarah B.Chief Medical Officer
GrantStock Option (Right to Buy) · Derivative 84,000 $0.00 Strike: $1.32 $0.00
Disclosure

SEC source: 0000950170-25-050098 · ownership.xml · derivative · entry 2

Noonberg Sarah B. · CIK 0001706301 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,000

Underlying: Common Stock · 84,000 shares

Expires 2035-03-31

F2 · derivative.exercise_date: 25% of the shares subject to this option shall vest and become exercisable on April 1, 2026, with the remainder vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document
April 01, 2025 Filed Apr 3, 2025 11:56 UTC
Noonberg Sarah B.Chief Medical Officer
GrantCommon Stock 14,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-050098 · ownership.xml · nonDerivative · entry 1

Noonberg Sarah B. · CIK 0001706301 · Chief Medical Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,374

F1 · shares: These shares represent restricted stock units ("RSUs"). 25% of the RSUs shall vest on June 5, 2026, with the remainder vesting in 12 equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer on each such vesting date.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.